Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
Open Access
- 14 November 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (48), 19757-19762
- https://doi.org/10.1073/pnas.1218260109
Abstract
Chronic infection with hepatitis C virus (HCV) is an important cause of end stage liver disease worldwide. In the United States, most HCV-related disease is associated with genotype 1 infection, which remains difficult to treat. Drug and vaccine development was hampered by inability to culture patient isolates representing HCV genotypes 1–7 and subtypes; only a recombinant 2a genome (strain JFH1) spontaneously replicated in vitro. Recently, we identified three mutations F1464L/A1672S/D2979G (LSG) in the nonstructural (NS) proteins, essential for development of full-length HCV 2a (J6) and 2b (J8) culture systems in Huh7.5 cells. Here, we developed a highly efficient genotype 1a (strain TN) full-length culture system. We initially found that the LSG substitutions conferred viability to an intergenotypic recombinant composed of TN 5′ untranslated region (5′UTR)-NS5A and JFH1 NS5B-3′UTR; recovered viruses acquired two adaptive mutations located in NS3 and NS4B. Introduction of these changes into a replication-deficient TN full-length genome, harboring LSG, permitted efficient HCV production. Additional identified NS4B and NS5B mutations fully adapted the TN full-length virus. Thus, a TN genome with 8 changes (designated TN cell-culture derived, TNcc) replicated efficiently and released infectious particles of ∼5 log10 focus-forming units per mL; passaged TNcc did not require additional changes. IFN-α and directly acting antivirals targeting the HCV protease, NS5A, and NS5B, each inhibited full-length TN infection dose-dependently. Given the unique importance of genotype 1 for pathogenesis, this infectious 1a culture system represents an important advance in HCV research. The approach used and the mutations identified might permit culture development for other HCV isolates, thus facilitating vaccine development and personalized treatment.This publication has 52 references indexed in Scilit:
- Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious CloneJournal of Virology, 2012
- Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma CellsAntimicrobial Agents and Chemotherapy, 2012
- Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strainsProceedings of the National Academy of Sciences of the United States of America, 2012
- Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1Journal of Virology, 2012
- Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factorNature Medicine, 2012
- Non-genotype-specific role of the hepatitis C virus 5′ untranslated region in virus production and in inhibition by interferonVirology, 2011
- Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus InfectionJournal of Virology, 2003
- Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzeesProceedings of the National Academy of Sciences of the United States of America, 2002
- Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian townJournal of Hepatology, 2000
- Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United StatesJournal of Viral Hepatitis, 2000